Podcasts about healthcare technology

“They say it takes a village to raise a child. I really think it takes a village to treat a patient,” says Dr. Lanae Mullane, a naturopathic doctor and clinical strategist who has spent years at the forefront of bridging functional medicine, nutraceutical development, and digital health. In this episode of Raise the Line, host Lindsey Smith explores Dr. Mullane's view that naturopathic medicine complements conventional care by expanding -- not replacing -- the clinical toolkit, and that collaboration should be the future of medicine. “At the end of the day, collaboration and connection create the best outcomes for the people we serve,” she says. Their in-depth conversation also spans the shifting landscape of women's hormone health, including the perimenopausal transition and long-overdue calls for research equity. “We're not just smaller versions of men. We need to have dedicated research for us.” Tune in to learn about the importance of grounding health in sustainable habits, rethinking midlife care for women, and how to help patients take ownership of their health.Mentioned in this episode:Joi + BlokesSuppCoDr. Mullane's Clinical Website If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

“It's kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played a key role in ushering in this new era of diabetes care, leading or participating in over 200 clinical studies on this class of drugs and others. “Nothing has impacted diabetes care like the GLP-1 receptor agonists. I have lots of patients whose diabetes was never well controlled who have seen all their metabolic problems essentially resolved.”  In this fascinating conversation with Raise the Line host Lindsey Smith, Dr. Buse not only explains how these drugs work, but also provides a clear-eyed look at side effects, and addresses issues of cost and access. Join us for the remarkable story – including the role played by Gila monsters -- behind one of the biggest developments in medicine over the past several years from a world renowned diabetes researcher and clinician. Mentioned in this episode:UNC School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Over 3 million clinicians around the world depend on UpToDate to guide patient care, and now the gold standard in clinical decision support is integrating generative AI. But in a world where AI models often hallucinate, how do you build something that doctors can actually trust?In this episode, Halle talks with Dr. Holly Urban, VP of Business Development and Strategy at Wolters Kluwer Health, about UpToDate Expert AI, a new tool trained exclusively on UpToDate's physician-authored content — not the open internet — and what it means for the future of medicine.We cover:

Send us a textWill the $50 billion rural transformation fund save rural hospitals or hasten their demise?  In this episode of CareTalk, hosts David E. Williams and John Driscoll debate whether CMS's plan to reshape rural healthcare can actually work.

“It wasn't a profession, it was a way of life,” observes internationally respected psychiatrist Dr. Nasser Loza, reflecting on a century-long family legacy in mental health care that began when his grandfather founded The Behman Hospital in Cairo. In this candid Raise the Line conversation with host Michael Carrese, Dr. Loza traces the transformation of psychiatry he's witnessed in his long career as increases in classifications, payment bureaucracy, reliance on pharmaceuticals, and technological disruption have each left their mark. The cumulative costs associated with these changes have, he laments, pushed care out of reach for many and hindered the human connection that is key to the discipline. He describes his prescription for countering these trends as a focus on effective and modest aims. “Rather than saying, come and see me in therapy for five years and I will make a better person out of you, I think focusing on symptom-targeted help is going to be what is needed.”  In this wide-ranging interview, you'll also learn about progress on advancing the rights of mental health patients and lowering stigmas, how to manage the rise of online therapy and use of AI chatbots, and the importance of empathy and transparency in mental health counseling. Don't miss this valuable perspective on a critically important dimension of healthcare that's informed by decades of experience as a clinician, government official and global advocate. Mentioned in this episode:The Behman HospitalMaadi Psychology Center If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients.  Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their  families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Most people spend over 30 hours a year dealing with customer service—on hold, repeating account numbers, and navigating endless phone trees. But what if AI could fix that without losing the human touch?Clay Bavor, co-founder of Sierra (now valued at $10B) and former VP at Google, joins us to explore how AI agents are reshaping how companies interact with customers and what that means for the most complex service industry in the world: healthcare.We cover:

Send us a textThe digital front door to healthcare is jammed, and it's costing patients, providers, and payers alike.In this episode of CareTalk Executive Features, host David Williams talks with Dr. Ashish Mandavia, CEO and cofounder of Sohar Health, about how AI and automation can transform eligibility and benefits verification from a frustrating bottleneck into a seamless, real-time process.

“Giving learners options gives them a better learning experience. It's more holistic and more comprehensive,” says Sean Moloney, CEO and founder of EmbodyXR, an extended reality platform focused on the use of immersive technologies in medical education. In this eye-opening Raise the Line conversation, Moloney explains how AI-powered extended reality (XR) --which integrates augmented, virtual, and simulation-based environments -- allows learners to interact with patients, explore multiple diagnostic choices, and experience varied outcomes based on their decisions. The result, he notes, is not only stronger engagement in learning, but a measurable improvement in understanding. Despite these gains, Moloney is quick to point out that he sees these technologies as complements to traditional training, not substitutes for it. “We'll never replace in-person teaching,” he says, “but we can make learners even better.” Beyond training future clinicians, the EmbodyXR platform is also offering new modes of patient and caregiver education, such as augmented reality guidance for using medical devices at home. Join host Lindsey Smith as she explores how EmbodyXR achieves and maintains clinical accuracy, the connectivity it offers between headsets, personal computers and mobile devices, and other capabilities that are shaping the future of how healthcare professionals and patients will learn. Mentioned in this episode:EmbodyXR If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Why has America struggled so much to effectively manage the opioid use crisis? One of the answers, as you'll learn in this eye-opening episode of Raise the Line, is rooted in laws and attitudes from the early 20th century that removed addiction from the realm of medicine and defined it as a moral failing.  “The federal Harrison Act of 1914 forbade any physician from prescribing opioids to people with addiction, so it became more the purview of law enforcement or behavioral health or religion,” says Dr. Melody Glenn, who regularly confronts the consequences of this history during shifts in the emergency department at Banner-University Medical Center in Tucson, Arizona. And as Glenn explains to host Caleb Furnas, the resulting stigma associated with addiction has extended to the treatments for it as well, especially methadone, despite its effectiveness. Drawing on her dual expertise in emergency and addiction medicine, Glenn dispels misconceptions that medication-assisted treatment merely replaces one addiction with another, and emphasizes that harm reduction is critical to saving lives. Her desire to break prevailing stigmas led her to discover the story of Dr. Marie Nyswander, who pioneered methadone maintenance therapy in the 1960s and is featured in Dr. Glenn's new book, Mother of Methadone: A Doctor's Quest, a Forgotten History, and a Modern-Day Crisis. You'll leave this instructive interview understanding the roots of our flawed approach to addiction treatment, meeting an overlooked pioneer in the field, and admiring a devoted and compassionate physician who is following in her footsteps.  Mentioned in this episode:Banner-University Medical CenterMother of Methadone book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This milestone 200th(!!!) episode of The Heart of Healthcare Podcast features none other than Dr. Tom X. Lee, the serial physician-founder behind Epocrates (acquired for $293M), One Medical (acquired by Amazon for $3.9B), and now Galileo, a tech-enabled medical group aiming to rewire care delivery from the ground up.We cover:

“We don't view a person with chronic pain as someone who has a chronic illness and the effect of that is we can't follow patients continuously over prolonged periods of time,” says Dr. Jacob Hascalovici, a neurologist and pain specialist based in New York City.  In co-founding Bliss Health, Dr. Jacob, as he is known, has set out to create a continuous care model for chronic pain treatment that matches the approach taken for patients with diabetes or high blood pressure. The Bliss Health formula includes an initial meeting with a physician that produces a care plan; remote therapeutic monitoring on an ongoing basis; and a monthly meeting with a nurse to review data and determine next steps, including additional appointments with physicians as needed.  All of this occurs via a digital platform which provides a welcome option for patients with mobility issues and can fill gaps in access to specialists, especially in rural areas. Dr. Jacob is also hoping to make chronic pain patents feel respected, which is not always the case in their encounters with the healthcare system. “Because pain is not something that can be seen or measured, oftentimes patients feel marginalized, dismissed and disempowered by providers.” Join Raise the Line host Lindsey Smith for a valuable conversation that also touches on policy changes that could strengthen telemedicine, and has details on the first non-opioid based pain medication to receive FDA approval in over 20 years.Mentioned in this episode:Bliss Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Send us a textMedicaid covers nearly 90 million Americans, but coverage doesn't always equal health.What if the real driver of outcomes isn't the doctor's office or an app, but the communityitself?In this episode of CareTalk Executive Features, WiderCircle co-founder and CEO Darin Buxbaum joins David Williams to share how peer-led circles and community engagement are improving health outcomes, boosting member trust, and delivering value for health plans.

In recent months, public health advocates in the United States have raised concerns about proposed changes to vaccine policy, cuts to food assistance programs, rollbacks of environmental protections and reductions in public health staffing. Chief among them has been Dr. Georges Benjamin who, as executive director of the American Public Health Association (APHA) since 2002, has led national efforts to create a healthier America. Raise the Line host Lindsey Smith recently sat down with Dr. Benjamin to understand more about the current state of public health and explore the path forward, and learned that a top priority for APHA is battling the misinformation that Dr. Benjamin believes is fueling support for many of these changes. “The challenge we have right now is that as a society, we've gone into our little corners and live in our own ecosystems. More people are getting their information from a single source and they're not validating that information to make sure that it's true.” Tune into this thoughtful and timely conversation to hear Dr. Benjamin's advice for curbing the spread of misinformation, how APHA is trying to help people understand the value of public health initiatives, and what the U.S. can learn from other countries about improving public health. Mentioned in this episode:American Public Health Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Happy Q4 Heart of Healthcare Listeners! We're back with your monthly Digital Health Download, where we discuss the biggest industry headlines of the month. We cover:

Send us a textEvery 90 minutes, someone in the U.S. is diagnosed with ALS — a devastating disease that has long resisted conventional research and treatment efforts.In this episode of Caretalk, Tris Dyson, Founder and Managing Director of Challenge Works, joins host John Driscoll to discuss how prize-based innovation and crowdsourcing could unlock new breakthroughs. Dyson shares his personal journey, why shifting incentives matters, and how bold new models can spark hope for ALS patients and families worldwide.

“Probably the most exciting thing I've seen in gene therapy over the last ten years is we now have a lot of tools for selective delivery, which will hopefully make treatments more safe and a lot more successful,” says Dr. Jessica Duis, a geneticist and pediatrician focused on the management of individuals with complex, rare disorders. Dr. Duis, who has worked on several gene therapies that are now approved or progressing through the accelerated approval pathway, is currently VP of Clinical Development at GondolaBio, a clinical-stage biopharmaceutical company focused on developing therapeutics for genetic diseases. As you'll learn in this Year of the Zebra episode with host Lindsey Smith, Dr. Duis is encouraged by other recent advances in genetic technology as well, and thinks momentum will grow as breakthrough treatments emerge. “I think we're hopefully going to continue to see companies that are working in rare disease be more successful and really drive how regulators think about making decisions in terms of bringing treatments to patients. I think we're at the tip of the iceberg in terms of the future of truly transformational therapies.”  This wide ranging conversation also explores Dr. Duis' team approach to patient care, her work on clinical endpoints, the importance of patient communities, and her book series, Rare Siblings Stories.Mentioned in this episode:GondolaBioRareDiseaseDocElsevier Healthcare Hub on Rare DiseasesRare Sibling Stories If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Cancer drugs cost more than ever, yet survival benefits are often modest—and in some cases, patients can't even access the care that already exists. After losing his father, Steve Jobs, to pancreatic cancer, Reed Jobs committed himself to making this the last generation that loses parents to the disease.Reed now leads Yosemite, a venture fund spun out of Emerson Collective in 2023, alongside Investor Matt Bettonville. Yosemite pairs life sciences and digital health investments with a grantmaking model to accelerate cancer research and ensure breakthroughs actually reach patients.We cover:

Some founders win support because of their product, others because of their story. In healthcare, where trust is everything, the ability to tell a compelling and authentic narrative can make or break a company.On this episode, Halle talks with longtime friend and colleague Christina Farr—reporter turned investor and now author of The Storyteller's Advantage. Chrissy has spent thousands of hours hearing startup pitches, advising founders, and studying what makes certain stories resonate while others fall flat. She shares insights from her years as a journalist and investor, and lessons from her new book on how narrative power shapes companies and industries.We cover:

With nearly one in ten newborns in the US requiring care in a Neonatal Intensive Care Unit, the importance of NICUs has never been more clear. On today's episode of Raise the Line, we're shining a light on the extraordinary world of NICUs with Lindsay Howard, a veteran nurse with over 17 years of experience caring for premature and critically ill infants. She currently works in a Level IV NICU at Children's Memorial Hermann Hospital in Houston, one of the most advanced neonatal units in the country. “We call ourselves ‘the ER of the neonate world' because we're never full. We have to make space no matter what comes in off the street, and at the biggest medical center in the world, we see all the things,” she explains. In this enlightening conversation with host Lindsey Smith, Howard describes how advances in medicine have made it possible to provide more types of care for younger and smaller babies, creating a need for NICU nurses to develop subspecialties. In her case, Howard is on a dedicated team that handles the placement and maintenance of all central line IVs, and has earned certifications in neonatal and pediatric chemotherapy and biotherapies. “We see babies that we may not have seen before being born with cancerous tumors who need chemotherapy to try and eliminate it, or just give them more time with their family.” This is a revealing look inside the workings of a top tier NICU where you'll learn about approaches to care that support healthy neurodevelopment, how clinical staff handle the emotional challenges of the job, and how her own experience as a mother with twins needing NICU care impacted her work.  Mentioned in this episode:Children's Memorial Hermann Hospital If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Send us a textHealthcare sits on mountains of valuable data, but compliance bottlenecks prevent organizations from unlocking its potential.In this Executive Feature episode of Caretalk, Shubh Sinha, CEO and co-founder of Integral, explains how his company is changing that by treating data infrastructure and compliance as one unified system rather than separate processes.

Thanks to improved accuracy and new form factors, wearables have evolved from novelty step counters to tools that can predict illness, nudge healthier behaviors, and even influence alcohol consumption. But can they really bridge the gap between consumer wellness and enterprise healthcare?In this episode, ŌURA CEO Tom Hale discusses the lessons his team has learned from developing one of the most widely used health-tracking devices. We explore what draws people to wearables, what sustains their engagement, and how these tools may be shaping behavior and healthcare itself. We cover:

Send us a textHave you ever had your health plan deny a treatment that your doctor says you need? Well, you're not alone. But there's good news: People who appeal insurance denials often win. In this episode of CareTalk Podcast: Healthcare. Unfiltered., hosts John Driscoll and David E. Williams dig into the history of prior authorization, why denials are so common, and what patients can do to fight back.

“When you think about where we were as a country before Medicare and Medicaid were created and where we are now, it's an incredible story,” says Chiquita Brooks-LaSure, who until earlier this year was the administrator for the Centers for Medicare and Medicaid Services (CMS). In a recent essay for The Century Foundation, where she is now a senior fellow, Brooks-LaSure used the 60th anniversary of enactment of those foundational insurance programs to help put their impact on individual Americans, the healthcare system and society at large in perspective. One prominent example is the desegregation of hospitals, which was achieved in part by withholding reimbursements for care unless facilities served Blacks as well as whites. Another is making it possible for more people with disabilities to live at home instead of in institutional settings. But as you'll hear in this probing Raise the Line conversation with host Lindsey Smith, Brooks-LaSure worries that many gains in coverage and other progress made over the years through Medicare, Medicaid and the Child Health Insurance Program (CHIP) are at risk because of a new federal law that calls for a trillion dollar decrease in spending, resulting in potentially millions of people losing their coverage, cuts to clinical staff and medical services, and the closure of hospitals and clinics, especially in rural areas. “Most rural hospitals in this country are incredibly dependent on both Medicare and Medicaid to keep their doors open and there's an estimate that over 300 hospitals will close as a result of this legislation, so that, I think, is a place of incredible nervousness.” Whether you are a patient, provider, policymaker or health system leader, this is a great opportunity to learn from an expert source about the range of potential impacts that will flow from changes to critically important insurance programs that provide coverage to 40% of adults and nearly 50% of children in the U.S. Mentioned in this episode:The Century FoundationEssay on 60th Anniversary of Medicare & Medicaid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

AI companies are hitting growth milestones in record time—some reaching $100 million in revenue in just two years. But while this pace feels familiar in tech, healthcare has always been slower to adopt new tools. That may finally be changing.Kent Bennett and Sofia Guerra of Bessemer Venture Partners join Steve Kraus to unpack findings from Bessemer's State of AI 2025 report and what they mean for healthcare. From “supernovas” and “shooting stars” to the rise of systems of action, they explore how AI is reshaping not only software businesses but also the way doctors, health systems, and patients interact with technology.We cover:

Send us a textAccess to healthcare in the U.S. is broken, with millions forced to choose between essential needs and seeing a doctor. Traditional clinics are too costly to scale, and telemedicine has hit adoption limits. In this episode of CareTalk, John Driscoll sits down with Karthik Ganesh, CEO of OnMed, to discuss how OnMed's “clinic in a box” is expanding access to care. Ganesh shares his journey across healthcare, why access has always been his passion, and how OnMed's innovative care stations blend the trust of in-person visits with the scalability of telemedicine to address one of the nation's most pressing healthcare challenges.

It seems there are news stories every week about the accelerating pace of innovation in gene therapy, but only about 50 therapies have been approved so far by the US Food and Drug Administration. Our guest today, Dr. Bobby Gaspar, leads a UK-based biotech company, Orchard Therapeutics, that developed one of those treatments using gene-modified stem cells in your blood that self-renew, so a single administration can give you potentially a lifelong effect. “Our approach is about correcting those hematopoietic stem cells and allowing them to give rise to cells that can then correct the disease,” explains Dr. Gaspar.  The therapy in focus is lenmeldy, the first approved treatment for metachromatic leukodystrophy, also known as MLD, a devastating inherited disorder that affects roughly 600 children worldwide. But Dr. Gaspar is optimistic that learnings from Orchard's work on MLD could be useful in treating much more common disorders including frontotemporal dementia, Crohn's disease and others. This highly informative conversation with host Lindsey Smith also explores the importance of newborn screening, community collaboration in advancing clinical trials for rare diseases, and a future in which each gene therapy will be used as a tool for specific applications.  “There will be many gene therapies available, some of which will become the standard of care for certain diseases, but it won't be for every disease.”Mentioned in this episode:Orchard Therapeutics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Send us a textHealthcare spending continues to surge, with pharmacy costs now representing 30-40% of total healthcare spend.   In this episode of CareTalk Executive Features, David Williams speaks with Dr. Alan Pannier, SVP of Product Strategy at SmithRx, about how legacy PBMs' misaligned incentives drive up costs, the toll on patients, employers, and independent pharmacies, and how a modern PBM model focused on transparency, fair reimbursement, and aligned incentives could finally fix what's broken in pharmacy benefits.

Healthcare's “back-to-school” season delivered no shortage of big headlines! From Epic's big leap into AI to a looming insurance “blood bath,” Steve and Michael break down the stories that shaped digital health this month.We cover:

Send us a textForget about the price of eggs. It's healthcare costs that are rising fast. Double digit increases are coming for 2026 and cost sharing is rising for employees. Weight loss drugs like Ozempic are adding billions to the bill and AI is a wild card, which could bring costs down or make them rise even faster.  In this episode, David E. Williams and John Driscoll unpack what's driving the rising cost of healthcare and what it means for the future.

You are in for a dose of inspiration in this episode of Raise the Line as we introduce you to a rare disease patient who was a leading force in establishing the diagnosis for her own condition, who played a key role in launching the first phase three clinical trials for it, and who is now coordinating research into the disease and related disorders at one of the nation's top hospitals. Rebecca Salky, RN, was first afflicted at the age of four with MOGAD, an autoimmune disorder of the central nervous system that can cause paralysis, vision loss and seizures. In this fascinating conversation with host Lindsey Smith, Rebecca describes her long and challenging journey with MOGAD, her work at the Neuroimmunology Clinic and Research Lab at Massachusetts General Hospital, and the importance of finding a MOGAD community in her early twenties. “There's a sense of power and security when you have others on your side. You're not alone in this journey of the rare disease,” she explains. Be sure to stay tuned to learn about Rebecca's work in patient advocacy, her experience as a nurse, and the three things she thinks are missing in the care of rare disease patients as our Year of the Zebra series continues.Mentioned in this episode:The MOG ProjectNeuroimmunology Clinic & Research Lab at Mass General If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Welcome back to Ditch the Lab Coat! In this episode, host Dr. Mark Bonta sits down with Dr. William Cherniak, an emergency physician, global health leader, and CEO of Rocket Doctor—a Canadian tech company on a mission to shake up how we access healthcare. As the world continues to grapple with the lessons learned from COVID-19, Dr. Cherniak and Dr. Bonta dive deep into the evolution of virtual care and its role in both episodic and chronic healthcare.Together, they challenge the misconceptions around virtual medicine, exploring how digital innovation is not just a convenient alternative but often a superior solution for patients who need fast, efficient, and ongoing medical attention. From navigating Canada's complex healthcare policies to leveraging AI and Bluetooth-enabled devices, Dr. Cherniak shares his journey as a physician-entrepreneur working to make healthcare more accessible—whether you're managing blood pressure from your living room or urgently treating poison ivy without a trip across town.Tune in as we unravel the myths of hands-on-only healthcare, the future possibilities of remote diagnostics and procedures, and what it will take for medicine to truly enter the 21st century. If you're curious about how virtual care is changing the patient-doctor relationship, cutting through red tape, and building a compassionate, tech-savvy future, this is an episode you can't miss.(https://www.linkedin.com)(http://rocketdoctor.io/)Episode Lessons 1 – Virtual Care Is Effective – Virtual healthcare can match or even surpass in-person care for many conditions, especially when accessibility is an issue.2 – Breaking Down Healthcare Barriers – Virtual care improves access for patients struggling with long waits or limited transportation to clinics.3 – Episodic vs. Chronic Care Needs – Healthcare isn't just for chronic patients; episodic care can be efficiently managed through modern virtual models.4 – Innovation Born From Necessity – Rocket Doctor's creation was driven by gaps in primary care, especially for those without family doctors.5 – Team-Based Medical Support – Virtual platforms enable teams of physicians to support each other, ensuring continuity even when one doctor is away.6 – Navigating Bureaucracy and Policy – Different provinces and health systems determine how virtual care can be provided and reimbursed, affecting implementation.7 – Seeing Beyond Clinic Walls – Virtual visits provide unique insights into patients' home and social environments, revealing valuable context for care.8 – Tech Empowers Doctors and Patients – Electronic records, AI tools, and Bluetooth devices streamline tasks, allowing more focus on patient care and faster follow-up.9 – Busting Medical Tradition Myths – Not every visit needs physical examination; much required care can be accurately delivered without in-person touch.10 – Envisioning Healthcare's Future – Real integration of AI, seamless records sharing, and patient-driven portals will further revolutionize how care is delivered virtually.Want me to bold all the lesson titles for consistency, or keep only the last one bold as the highlight?Episode Timestamps00:00 – Medical Podcast Disclaimer 05:28 – Reimagining Virtual Care in Canada 08:04 – Canadian Tech-Driven Medical Practice 11:54 – Bureaucratic Challenges in Healthcare 13:39 – Embracing Virtual Healthcare 19:53 – Virtual Care: Beneficial vs. In-Person 20:54 – Canada's Acute vs. Preventative Care 26:14 – Virtual Care Evolution 2019 30:08 – Healthcare Innovation and Streamlining 32:59 – Home Ultrasound Study for Pneumonia 35:40 – Virtual Care: Medicine's Evolution 37:42 – Science Skepticism Podcast Promo DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.    Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

Healthcare costs keep climbing, and yet patients and employers often feel powerless to change the system. What if outsiders—those not steeped in the traditions of healthcare—are actually the ones best positioned to fix it?This special episode is a reshare from The Benefits Playbook podcast, where Halle joins Collective Health CEO Ali Diab. Together, they unpack what it takes to make health benefits simpler, more transparent, and more consumer-focused.We cover:

Send us a textClinical trials are the backbone of medical progress, but they've become increasingly complex, costly, and slow. Can technology smooth the process without compromising rigor?Scott Chetham, Founder and CEO of Faro Health and former clinical operations leader at Verily, explains why outdated processes bog down research and how Faro's digital trial platform is making studies faster, more efficient, and more patient-friendly. By transforming static documents into connected, intelligent systems, Faro helps sponsors and regulators streamline design, reduce amendments, and improve trial outcomes.

Hospitals are under immense pressure: burned-out clinicians, outdated systems, and rising costs have made delivering care harder than ever. Tanay Tandon, founder and CEO of Commure, shares how his team is rethinking hospital infrastructure by combining AI, forward-deployed engineering, and a provider-first mindset. Backed by over $750M in funding, Commure is using strategic M&A and next-gen tools like ambient AI to reduce administrative burden, improve revenue cycle operations, and protect clinical staff.We cover:

In this episode of Elevate Care, host Liz Cunningham sits down with Patrick Hemstreet, Senior Director of Strategy at AMN Healthcare, to tackle the pressing issue of the physician shortage crisis. Together, they explore the evolving role of locum tenens in healthcare staffing, the impact of workforce technology and VMS systems, and how advancements in AI and automation are reshaping the industry. From the challenges of credentialing to the opportunities for younger physicians, this episode dives deep into the strategies and innovations needed to address the growing demand for healthcare professionals.Chapters00:00 - Understanding the Physician Shortage Crisis02:56 - The Role of Locum Tenens in Healthcare Staffing05:51 - Workforce Technology and VMS in Healthcare09:03 - The Future of Locum Tenens and Physician Staffing11:55 - Leveraging Technology for Efficient Staffing14:45 - Navigating Challenges in Locum Tenens Management17:51 - The Impact of AI and Data on Healthcare Staffing20:50 - Trends and Innovations in Physician ShortagesResourcesChoosing a Flexible Workforce Technology for Your OrganizationRevolutionize Your Locums Staffing with ShiftWise Flex About Patrick HemstreetPatrick Hemstreet is a distinguished healthcare executive with over 20 years of leadership experience, currently serving as Senior Director of Strategy at AMN Healthcare, a leader in innovative talent solutions for healthcare organizations. Patrick is known for his technology expertise. Patrick has driven innovations around cutting-edge solutions, including AI applications, Vendor Management Systems (VMS), and workforce optimization platforms. He leads multiple market intelligence programs at  AMN.  Patrick has held various positions as a healthcare executive including Chief Strategy Officer and President.  Patrick was involved in the envisioning and building of early gen healthcare SaaS platforms that provided telehealth, EHR, and billing throughput functionalities. Patrick holds an MBA from Texas Tech University, multiple healthcare certifications (including the certification in intraoperative neurophysiologic monitoring), and is a published sci-fi author and former U.S. Navy member. Sponsors: Learn how AMN Healthcare's workforce flexibility technology helps health systems cut costs and improve efficiency. Click here to explore the case study and discover smarter ways to manage your resources!Discover how WorkWise is redefining workforce management for healthcare. Visit workwise.amnhealthcare.com to learn more.About The Show: Elevate Care delves into the latest trends, thinking, and best practices shaping the landscape of healthcare. From total talent management to solutions and strategies to expand the reach of care, we discuss methods to enable high quality, flexible workforce and care delivery. We will discuss the latest advancements in technology, the impact of emerging models and settings, physical and virtual, and address strategies to identify and obtain an optimal workforce mix. Tune in to gain valuable insights from thought leaders focused on improving healthcare quality, workforce well-being, and patient outcomes. Learn more about the show here. Connect with Our Hosts:Kerry on LinkedInNishan on LinkedInLiz on LinkedIn Find Us On:WebsiteYouTubeSpotifyAppleInstagramLinkedInXFacebook Powered by AMN Healthcare

A conversation with Sahil DiwanThe future of healthcare is proactive.And that can start from the smallest of treatments - as simple as getting your ears cleaned.Enter Sahil Diwan, Co-Founder and CEO of SafKan Health, the medtech company behind OtoSet, the first FDA-cleared automated ear-cleaning headphones.Sahil and his brother have designed a product with mass appeal - it's regularly going viral on social media with millions of views. With people queuing up to try it out, Sahil takes us through how this evolution in ear care is transforming an often-neglected personal hygiene procedure - for patients and providers.—- We spoke about how OtoSet was created, the process of FDA approval, the connection between neglected ear care and health issues, and why consumer-led, tech-enabled proactive care paints a positive future.Follow me on Instagram and Facebook @ericfethkemd and checkout my website at www.EricFethkeMD.com. My brand new book, The Privilege of Caring, is out now on Amazon! https://www.amazon.com/dp/B0CP6H6QN4

Send us a textMost of us go to the doctor, get labs drawn, maybe even have a scan — and then never see the full picture of our own health. That's changing.In this episode of The Daily Apple, Kevin talks with Travis Bond, founder of Bio Insights, about the future of electronic medical records (EMRs) and why they're not just for doctors. EMRs are becoming the backbone of how patients can actually see, understand, and act on their health information.This isn't a tech episode for physicians. It's a conversation about how you can be more connected, informed, and in charge of your own health journey. From making sure your care team is on the same page, to finally having your results and history in one place, EMRs are making it possible to move from confusion to clarity.In this episode:Why electronic medical records matter for patients, not just providersHow EMRs make it easier to track your own progress over timeThe difference between “data overload” and “actionable information”How a more connected record leads to better conversations with your doctorWhat the future looks like when patients actually own their health storyIt's not about replacing your doctor. It's about having the tools to understand what's happening — and make decisions with confidence. Prime Health Associates

One in four Americans is enrolled in Medicaid, yet the system designed to support them is constantly at risk—underfunded, politically vulnerable, and often overlooked.Dr. Alastair Bell, President and CEO of Boston Medical Center Health System, shares how his organization is reimagining what it means to care for underserved populations, while managing nearly 40% of Massachusetts' Medicaid enrollees. In this conversation, we explore the financial realities of running an “essential” hospital system, the opportunities and pitfalls of Medicaid ACOs, and why AI might deepen inequity if essential providers are left behind.We cover:

Three simple questions plague every American seeking healthcare: Where should I go? When can I be seen? And how much will it cost me? Despite seeming basic, these questions have remained largely unanswerable—until now.In this episode, we explore how Heather Fernandez, co-founder and CEO of Solv, is building the infrastructure behind same-day care for 210 million Americans. We discuss how AI is finally cracking the code on price transparency and why workflow complexity can be a competitive moat in healthcare.We cover:

A new federal law is reshaping how healthcare is paid for and delivered in America.In this episode, Steve sits down with health policy expert Joe Mercer to unpack the details of the One Big Beautiful Bill Act. It's the most significant healthcare legislation since the ACA, with ripple effects across Medicaid, rural hospitals, and the ACA exchange.We cover:

John Golden's Linkedin: https://www.linkedin.com/in/goldenjohn/Vital Neuro Linkedin:  https://www.linkedin.com/company/vital-neuroChris Hoyd's Linkedin: https://www.linkedin.com/in/chrishoyd/ John Golden is the CEO of Vital Neuro. He has considerable experience in operational and technology leadership, and led the successful exit from EXOS, a previous company he founded and built, prior to joining Vital Neuro 7 years ago. John has spent his career dedicated to making high quality complex technologies into simple consumer products that people can use, and uses the Vital Neuro technology himself 3-4 times per day to stay on top of his game. John has led the company through the clinical development all the way to reality as a consumer facing product, with a guiding principle that neurofeedback technology should be as easy to use as regular headphones. Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

Fresh off a $243 million fundraise from Oak HC/FT and A16Z, Ambience Healthcare is on a mission to kill medical billing — and build “Iron Man suits for doctors.”Today we sit down with co-founder and CEO Mike Ng to talk about how Ambience is tackling one of healthcare's most painful problems: the administrative burden that eats up 73% of a clinician's day. We cover:

SummaryIn this conversation, Jennifer Darling and Warren Olson discuss the evolution of fire protection, the importance of continuing education, and the role of mentorship in the fire service. They explore Warren's extensive career, his involvement with the NFPA, and the challenges faced in fire safety regulations. The discussion highlights the significance of teaching and the impact of major fire incidents on current safety practices.takeawaysMICE aims to simplify continuing education for providers and administrators.Warren Olson has over 50 years of experience in fire protection.He emphasizes the importance of mentorship in the fire service.Generational changes have improved firefighter health and safety.Teaching has been a passion for Warren throughout his career.NFPA technical committees play a crucial role in developing fire safety codes.Challenges in fire safety regulations are influenced by special interest groups.Lessons from past fire incidents shape current safety practices.The pendulum of fire safety regulations swings with public perception.Warren's journey reflects the importance of continuous learning in fire protection.Sound Bites"I've been doing this a long time.""Teaching gives me the greatest joy.""The codes are being chipped away."Chapters00:00Introduction to MICE and TrackMyCE.io01:25Warren Olson's Journey in Fire Protection05:55Career Progression and Experiences in Fire Service11:52Generational Changes in Fire Service17:52The Importance of Teaching and Mentorship23:52Involvement with NFPA Technical Committees29:54Challenges in Fire Safety Regulations35:56Lessons from Major Fire Incidents41:33Reflections on Fire Safety and Future Directions

Dexcom generates more than $4 billion in annual revenue and has a market cap north of $30 billion, making it one of the biggest digital health companies in the world. And it all started with a better way to measure blood sugar.In this episode, Halle is joined by Kevin Sayer, CEO of Dexcom, the company that pioneered continuous glucose monitoring (CGM). Under Kevin's leadership, Dexcom scaled from $40 million to $4 billion in revenue, became the standard of care for people with diabetes, and is now expanding into consumer wellness with its direct-to-consumer product, Stelo.We cover:

Are healthcare supply chains ready for a technological revolution? In this episode of the CPO Rising Series hosted by Products That Count Resident CPO Renee Niemi, GHX CPO Archie Mayani speaks on transforming healthcare technology through customer-centric innovation. She shares her unique perspective on leveraging AI, balancing immediate customer needs with long-term strategic vision, and driving meaningful change in one of the most complex industries.

More than a thousand AI medical devices have FDA clearance, yet fewer than two percent of radiologists actually use them.In this episode, Steve sits down with Dr. Brian Anderson—CEO and co‑founder of the Coalition for Health AI—to unpack why trust, transparency, and regulation could make or break the next wave of AI‑powered medicine.We cover:

When Andrew Lacy launched Prenuvo, the medical establishment largely dismissed it as fringe. Now, some of those same skeptics are collaborating with him on research.In this episode, Halle and Michael sit down with Andrew, founder and CEO of Prenuvo, to unpack what it takes to build trust in an unconventional idea. He opens up about how a moment of personal reckoning led him to pivot from tech to healthcare—and why he believes early detection should be a fundamental right.We cover: